Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By

Showing results 201 - 210 of 239

Selected Filters:
7 February 2019

PrEP Implementation Pack: South Africa 2016-2017

A 2016-2017 implementation package for South Africa's PrEP Launch. Includes relevant policy and guidelines, tools for auditing facilities, IEC materials and tools for monitoring and evaluation.

Community/Advocacy, Demand Creation/Marketing, Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

Document
6 February 2019

The Landscape For End User Research: Mapping and Findings

The HIV Prevention Market Manager undertook an effort to map the landscape of ongoing and planned work on bringing HIV prevention to adolescent girls and young women and other populations in sub-Saharan Africa. This document provides a summary and analysis of the end-user projects and studies underway. This information can be used to inform collaborations…

Demand Creation/Marketing, Research, Service Delivery

Document
1 February 2019

Implementation Plan for HIV Pre-Exposure Prophylaxis in Zimbabwe 2018-2020

Government of Zimbabwe's plan for the sustainable implementation of PrEP from 2018-2020. Published by the Ministry of Health & Child Care.

Normative Guidance/Policies

Document
31 January 2019

Dapivirine Ring: The case for action

A 2017 report that lays out next steps for the ring as it nears a regulatory decision and the field prepares for product introduction.

Community/Advocacy

Document
28 January 2019

Dapivirine Ring Introduction Framework

The ring introduction framework highlights anticipated strengths, challenges, and key questions regarding introduction of the dapivirine ring in sub-Saharan Africa. It can be used by policymakers, implementers, and others planning for introduction of the dapivirine ring and other biomedical HIV prevention methods. The framework is based on several inputs including secondary research, interviews with key…

Demand Creation/Marketing, Financing & Costing, Monitoring & Evaluation, Research, Supply Chain Management

Document
18 January 2019

Prevention Market Manager: Analysis of BMGF-Funded PrEP Demonstration Projects

Beginning in 2013, the Bill & Melinda Gates Foundation supported seven early oral PrEP demonstration projects. The Prevention Market Manager project aggregated and analyzed the project results to inform oral PrEP rollout and new product demonstration projects. Click below for the findings. Two companion documents, Lessons from Seven Early Oral PrEP Demonstration Projects and What…

Monitoring & Evaluation, Research

Document
15 January 2019

SheConquers Workshop Videos

SheConquers, the South African national campaign that aims to improve the lives of adolescent girls and young women and their male peers in South Africa, produced several videos highlighting the thoughts and opinions of young people in relation to the topic of oral PrEP.

Community/Advocacy, Demand Creation/Marketing

External Link
8 January 2019

Kenya PrEP Communications Landscape Analysis

McCann Global Health conducted this situation analysis of all available communication on HIV prevention and PrEP for target audiences in Kenya. This analysis was used to identify gaps in market intelligence that should be further explored. The following presentation outlines the findings.

Demand Creation/Marketing

Document
17 December 2018

Zambia Consolidated Guidelines for Treatment & Prevention of HIV Infection (2018)

National strategy to combat HIV/AIDS, includes guidance on oral PrEP.

Normative Guidance/Policies

Document
17 December 2018

National Guidelines For HIV Prevention, Treatment and Care

It is recommended that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV negative persons who are exposed to prolonged and substantial risk of acquiring HIV infection as a part of a combination of other available HIV prevention methods.

Normative Guidance/Policies

Document